Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Interest Expenses: 2010-2025

Historic Interest Expenses for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $556000.0.

  • Cross Country Healthcare's Interest Expenses rose 109.09% to $556000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 415.51%. This contributed to the annual value of $2.2 million for FY2024, which is 7296.76% down from last year.
  • Per Cross Country Healthcare's latest filing, its Interest Expenses stood at $556000.0 for Q3 2025, which was up 109.09% from $549000.0 recorded in Q2 2025.
  • Cross Country Healthcare's 5-year Interest Expenses high stood at $3.9 million for Q2 2022, and its period low was $462000.0 during Q1 2024.
  • For the 5-year period, Cross Country Healthcare's Interest Expenses averaged around $1.7 million, with its median value being $671000.0 (2021).
  • Per our database at Business Quant, Cross Country Healthcare's Interest Expenses skyrocketed by 42473.92% in 2022 and then crashed by 8747.97% in 2024.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Interest Expenses stood at $2.8 million in 2021, then increased by 24.78% to $3.5 million in 2022, then plummeted by 83.33% to $586000.0 in 2023, then rose by 3.75% to $608000.0 in 2024, then fell by 8.55% to $556000.0 in 2025.
  • Its Interest Expenses was $556000.0 in Q3 2025, compared to $549000.0 in Q2 2025 and $543000.0 in Q1 2025.